CAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma: Your questions answered
Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape
Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape
The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly
Explore ways to improve time to result in critical pathways such as sepsis
Explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries
HALIX to provide large-scale GMP manufacture of AZD1222
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.
Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline
Explore topics such as rapid antimicrobial resistance testing and analysis of viral vectors to Raman spectroscopy and high-performance thin-layer chromatography
The kit is ideally suited to NGS library preparation from a low input, patient-derived sample types, such as nasal swabs
Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform
Researchers recommend that targeted nutrition should be urgently explored as a counter-measure to mitochondrial damage
Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Two different dosing regimens demonstrated efficacy with one showing a better profile
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide